Free Trial
OTCMKTS:BRTX

BioRestorative Therapies (BRTX) Stock Price, News & Analysis

BioRestorative Therapies logo
$1.60 -0.02 (-1.23%)
As of 04:00 PM Eastern

About BioRestorative Therapies Stock (OTCMKTS:BRTX)

Key Stats

Today's Range
$1.52
$1.65
50-Day Range
$1.52
$2.00
52-Week Range
$1.21
$2.55
Volume
296,383 shs
Average Volume
239,336 shs
Market Capitalization
$12.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioRestorative Therapies and its competitors with MarketBeat's FREE daily newsletter.

BRTX Stock News Headlines

This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
BRTX-100 Front and Center at ORS 2025
See More Headlines

BRTX Stock Analysis - Frequently Asked Questions

BioRestorative Therapies' stock was trading at $1.43 at the beginning of 2025. Since then, BRTX shares have increased by 11.9% and is now trading at $1.60.

BioRestorative Therapies's stock reverse split before market open on Wednesday, October 27th 2021.The 1-4000 reverse split was announced on Wednesday, October 27th 2021. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 27th 2021. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Shares of BRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioRestorative Therapies investors own include Tonix Pharmaceuticals (TNXP), Vaxart (VXRT), Inovio Pharmaceuticals (INO), Actinium Pharmaceuticals (ATNM), NVIDIA (NVDA), Onconova Therapeutics (ONTX) and American Graphite Technologies (AGIN).

Company Calendar

Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:BRTX
CIK
1505497
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.47)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.50 million
Net Margins
-13,728.83%
Pretax Margin
-13,728.83%
Return on Equity
-120.47%
Return on Assets
-114.48%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.81
Quick Ratio
14.81

Sales & Book Value

Annual Sales
$391 thousand
Price / Sales
30.71
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.65 per share
Price / Book
0.60

Miscellaneous

Outstanding Shares
7,505,000
Free Float
3,660,000
Market Cap
$12.01 million
Optionable
Not Optionable
Beta
75.28

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:BRTX) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners